Advertisement

European Archives of Oto-Rhino-Laryngology

, Volume 275, Issue 5, pp 1103–1110 | Cite as

Intratympanic steroid use for idiopathic sudden sensorineural hearing loss: current otolaryngology practice in Germany and Austria

  • L. Sutton
  • V. Schartinger
  • C. Url
  • J. Schmutzhard
  • D. Lechner
  • C. Kavasogullari
  • J. S. Sandhu
  • A. Shaida
  • R. Laszig
  • J. Loehler
  • S. Plontke
  • H. Riechelmann
  • M. Lechner
Otology

Abstract

Aims

The frequency of the use of intratympanic steroids (ITS) as a treatment for idiopathic sudden sensorineural hearing loss (ISSNHL) in Europe is still unknown and remains a contentious issue amongst otolaryngologists. We undertook a survey of otolaryngologists in Germany and Austria to establish if there is any professional consensus with which to form a protocol for its use.

Methods

A survey of 21 questions was distributed electronically to otolaryngologists in Germany and Austria and data on demographics, indications for intratympanic treatment, procedure, follow-up, and outcomes were analysed.

Results

We received 908 responses. 49.1% of otolaryngologists used ITS for ISSNHL. Of those otolaryngologists who use ITS, 73.7% do not use it as primary treatment. 20.6% use ITS in conjunction with oral steroids for primary treatment and only 5.8% use ITS as monotherapy for primary treatment. 90.5% use ITS as salvage therapy. 81.1% do not consider the use of ITS after 2 weeks from the onset of symptoms. 8.3% used a tympanostomy tube and while the most commonly used steroid was dexamethasone at a concentration of 4 mg/ml (61%), a wide variety or other steroids and concentrations were used.

Conclusions

This survey illustrates wide variation of current practice of intratympanic corticosteroid injection for ISSHL in Germany and Austria. In the absence of high-level evidence, knowing what current practice is allows clinicians to assess what they do against what their colleagues are doing, and if they do something very different, make them question their practice. Moreover, the obtained data will help to direct future clinical trials with the aim to compare the outcomes of more commonly used protocols.

Keywords

Adult Hearing loss Sudden hearing loss Intratympanic Steroids 

Notes

Acknowledgements

We would like to thank the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery (http://www.hno.org) and the Austrian Society of Oto-Rhino-Laryngology, Head and Neck Surgery (http://www.hno.at).

Compliance with ethical standards

Conflict of interest

L. Sutton declares that he has no conflict of interest. V. Schartinger declares that he has no conflict of interest. C. Url declares that he has no conflict of interest. J. Schmutzhard declares that he has no conflict of interest. D. Lechner declares that she has no conflict of interest. C. Kavasogullari declares that he has no conflict of interest. J.S. Sandhu declares that he has no conflict of interest. A. Shaida declares that he has no conflict of interest. R. Laszig declares that he has no conflict of interest. J. Loehler declares that he has no conflict of interest. S. Plontke declares that he has no conflict of interest. H. Riechelmann declares that he has no conflict of interest. M. Lechner declares that he has no conflict of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Supplementary material

405_2018_4958_MOESM1_ESM.docx (19 kb)
Supplementary material 1 (DOCX 19 KB)

References

  1. 1.
    Whitaker S (1980) Idiopathic sudden hearing loss. Am J Otol 1:180–183CrossRefPubMedGoogle Scholar
  2. 2.
    Plontke SK, Bauer M, Meisner C (2007) Comparison of pure-tone audiometry analysis in sudden hearing loss studies: lack of agreement for different outcome measures. Otol Neurotol 28(6):753–763CrossRefPubMedGoogle Scholar
  3. 3.
    Byl FM Jr (1984) Sudden hearing loss: eight years’ experience and suggested prognostic table. Laryngoscope 94:647–661CrossRefPubMedGoogle Scholar
  4. 4.
    Rauch SD (2008) Clinical practice. Idiopathic sudden sensorineural hearing loss. New Engl J Med 359(8):833–840CrossRefPubMedGoogle Scholar
  5. 5.
    Koltsidopoulos P, Biba A, Sismanis A, Tzonoun A, Seggas I (2013) Intratympanic and systemic steroids for sudden hearing loss. Otol Neurotol 34:771–776CrossRefPubMedGoogle Scholar
  6. 6.
    Klemm E, Deutscher A, Mösges R (2009) A present investigation of the epidemiology in idiopathic sudden sensorineural hearing loss. Laryngorhinootologie 88(8):524–527CrossRefPubMedGoogle Scholar
  7. 7.
    Olzowy B, Osterkorn D, Suckfüll M (2005) The incidence of sudden hearing loss is greater than previously assumed. MMW Fortschr Med 147(14):37–38PubMedGoogle Scholar
  8. 8.
    Wilson WR, Byl FM, Laird N (1980) The efficacy of steroids in the treatment of idiopathic sudden hearing loss. A double-blind clinical study. Arch Otolaryngol 106:772–776CrossRefPubMedGoogle Scholar
  9. 9.
    Meltser I, Canlon B (2011) Protecting the auditory system with glucocorticoids. Hear Res 281(1–2):47–55CrossRefPubMedGoogle Scholar
  10. 10.
    Trune DR, Canlon B (2012) Corticosteroid therapy for hearing and balance disorders. Anat Rec (Hoboken) 295(11):1928–1943CrossRefGoogle Scholar
  11. 11.
    Moskowitz D, Lee KJ, Smith HW (1984) Steroid use in idiopathic sudden sensorineural hearing loss. Laryngoscope 94:664–666CrossRefPubMedGoogle Scholar
  12. 12.
    Wei BP, Stathopoulos D, O’Leary S. Steroids for idiopathic sudden sensorineural hearing loss. Cochrane Database Syst Rev. 2013;(7):CD003998.  https://doi.org/10.1002/14651858.CD003998.pub3
  13. 13.
    Chandrasekhar SS, Rubinstein RY, Kwartler JA (2000) Dexamethasone pharmacokinetics in the inner ear: comparison of route of administration and use of facilitating agents. Otolaryngol Head Neck Surg 122:521–528PubMedGoogle Scholar
  14. 14.
    Parnes LS, Sun AH, Freeman DJ (1999) Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope 109:1–17CrossRefPubMedGoogle Scholar
  15. 15.
    Rauch SD, Halpin CF, Antonelli PJ, Babu S, Carey JP, Gantz BJ et al (2011) Oral vs intratympanic corticosteroid therapy for idiopathic sudden sensorineural hearing loss: a randomized trial. JAMA 305(20):2071–2079CrossRefPubMedGoogle Scholar
  16. 16.
    Crane RA, Camilon M, Nguyen S, Meyer TA (2015) Steroids for treatment of sudden sensorineural hearing loss: a meta-analysis of randomized controlled trials. Laryngoscope 125(1):209–217CrossRefPubMedGoogle Scholar
  17. 17.
    Liebau A, Pogorzelski O, Salt AN, Plontke SK (2017) Hearing changes after intratympanically applied steroids for primary therapy of sudden hearing loss: a meta-analysis using mathematical simulations of drug delivery protocols. Otol Neurotol 38(1):19–30CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Garavello W, Galluzzi F, Gaini RM, Zanetti D (2012) Intratympanic steroid treatment for sudden deafness: a meta-analysis of randomized controlled trials. Otol Neurotol 33(5):724–729CrossRefPubMedGoogle Scholar
  19. 19.
    Li H, Feng G, Wang H, Feng Y (2015) Intratympanic steroid therapy as a salvage treatment for sudden sensorineural hearing loss after failure of conventional therapy: a meta-analysis of randomized, controlled trials. Clin Ther 37(1):178–187CrossRefPubMedGoogle Scholar
  20. 20.
    Ng JH, Ho RC, Cheong CS, Ng A, Yuen HW, Ngo RY (2015) Intratympanic steroids as a salvage treatment for sudden sensorineural hearing loss? A meta-analysis. Eur Arch Otorhinolaryngol 272(10):2777–2782CrossRefPubMedGoogle Scholar
  21. 21.
    Gao Y, Liu D (2016) Combined intratympanic and systemic use of steroids for idiopathic sudden sensorineural hearing loss: a meta-analysis. Eur Arch Otorhinolaryngol 273(11):3699–3711CrossRefPubMedGoogle Scholar
  22. 22.
    Battaglia A, Lualhati A, Lin H, Burchette R, Cueva R (2014) A prospective, multi-centered study of the treatment of idiopathic sudden sensorineural hearing loss with combination therapy versus high-dose prednisone alone: a 139 patient follow-up. Otol Neurotol 35(6):1091–1098CrossRefPubMedGoogle Scholar
  23. 23.
    Günel C, Başal Y, Toka A, Eryılmaz A, Kurt Ömürlü I (2015) Efficacy of low-dose intratympanic dexamethasone for sudden hearing loss. Auris Nasus Larynx 42(4):284–287CrossRefPubMedGoogle Scholar
  24. 24.
    Siegel LG (1975) The treatment of idiopathic sudden sensorineural hearing loss. Otolarynol Clin North Am 8(2):467–473Google Scholar
  25. 25.
    Lavigne P, Lavigne F, Saliba I (2015) Intratympanic corticosteroids injections: a systematic review of literature. Eur Arch Otorhinolaryngol.  https://doi.org/10.1007/s00405-015-3689-3 PubMedGoogle Scholar
  26. 26.
    Belhassen S, Saliba I (2014) Intratympanic steroid injection as a salvage treatment for sudden sensorineural hearing loss. J Laryngol Otol 128(12):1044–1049CrossRefPubMedGoogle Scholar
  27. 27.
    Liebau A, Pogorzelski P, Salt AN, Zenner HP, Plontke SK (2017) Dependence of hearing changes after intratympanically applied steroids for primary therapy of sudden hearing loss: a meta-analysis using mathematical simulations of clinical drug delivery protocols. Otol Neurotol 38(1):19–30CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Ho HG, Lin HC, Shu MT, Yang CC, Tsai HT (2004) Effectiveness of intratympanic dexamethasone injection in sudden-deafness patients as salvage treatment. Laryngoscope 114(7):1184–1189CrossRefPubMedGoogle Scholar
  29. 29.
    Lee JB, Choi SJ, Park K, Park HY, Choo OS, Choung YH (2011) The efficiency of intratympanic dexamethasone injection as a sequential treatment after initial systemic steroid therapy for sudden sensorineural hearing loss. Eur Arch Otorhinolaryngol 268:833–839CrossRefPubMedGoogle Scholar
  30. 30.
    Wu HP, Chou YF, Yu SH, Wang CP, Hsu CJ, Chen PR (2011) Intratympanic steroid injections as a salvage treatment for sudden sensorineural hearing loss: a randomized, double-blind, placebo-controlled study. Otol Neurotol 32(5):774–779CrossRefPubMedGoogle Scholar
  31. 31.
    Xenellis J, Papadimitriou N, Nikolopoulos T, Maragoudakis P, Segas J, Tzagaroulakis A et al (2006) Intratympanic steroid treatment in idiopathic sudden sensorineural hearing loss: a control study. Otolaryngol Head Neck Surg 134(6):940–945CrossRefPubMedGoogle Scholar
  32. 32.
    Zhao D, Tong B, Wang Q, Hellstrom S, Duan M (2016) A comparison of effects of systemic and intratympanic steroid therapies for sudden sensorineural hearing loss: A meta-analysis. J Otol 11(1):18–23CrossRefGoogle Scholar
  33. 33.
    Kosyakov S, Atanesyan A, Gunenkov A, Ashkhatunyan E, Kurlova A (2011) Intratympanic steroids for sudden sensorineural hearing loss. J Int Adv Otol 7(3):323–332Google Scholar
  34. 34.
    Bird PA, Begg EJ, Zhang M, Keast AT, Murray DP, Balkany TJ (2007) Intratympanic versus intravenous delivery of methylprednisolone to cochlear perilymph. Otol Neurotol 28(8):1124–1130CrossRefPubMedGoogle Scholar
  35. 35.
    Bird PA, Murray DP, Zhang M, Begg EJ (2011) Intratympanic versus intravenous delivery of dexamethasone and dexamethasone sodium phosphate to cochlear perilymph. Otol Neurotol 32(6):933–936CrossRefPubMedGoogle Scholar
  36. 36.
    Salt AN, Hartsock JJ, Gill RM, Piu F, Plontke SK (2012) Perilymph pharmacokinetics of markers and dexamethasone applied and sampled at the lateral semi-circular canal. J Assoc Res Otolaryngol 13(6):771–783CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Salt AN, Plontke SK (2009) Principles of local drug delivery to the inner ear. Audiol Neurootol 14(6):350–360CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Plontke SK, Glien A, Rahne T, Mäder K, Salt AN (2014) Controlled release dexamethasone implants in the round window niche for salvage treatment of idiopathic sudden sensorineural hearing loss. Otol Neurotol 35(7):1168–1171PubMedPubMedCentralGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  • L. Sutton
    • 1
    • 2
  • V. Schartinger
    • 3
  • C. Url
    • 3
  • J. Schmutzhard
    • 3
  • D. Lechner
    • 3
  • C. Kavasogullari
    • 4
  • J. S. Sandhu
    • 5
  • A. Shaida
    • 6
  • R. Laszig
    • 7
  • J. Loehler
    • 8
  • S. Plontke
    • 9
  • H. Riechelmann
    • 3
  • M. Lechner
    • 1
    • 2
    • 3
    • 6
  1. 1.Head and Neck CentreUniversity College London Hospitals NHS TrustLondonUK
  2. 2.UCL Cancer InstituteUniversity College LondonLondonUK
  3. 3.Department of Otorhinolaryngology-Head and Neck SurgeryUniversity Hospital of InnsbruckInnsbruckAustria
  4. 4.LanarkshireUK
  5. 5.Northern General HospitalSheffield Teaching Hospitals NHS Foundation TrustSheffieldUK
  6. 6.Royal National Throat, Nose and Ear HospitalUniversity College London Hospitals NHS TrustLondonUK
  7. 7.Department of OtorhinolaryngologyUniversity Hospital of FreiburgFreiburgGermany
  8. 8.ENT ClinicBad BramstedtGermany
  9. 9.Department of Otorhinolaryngology, Head and Neck SurgeryUniversity Hospital HalleHalleGermany

Personalised recommendations